Adverse Drug Reactions in Pharmacy Practice: Risks Across Ages and Drug Classes

Medication is designed to heal, yet in pharmacy practice, adverse drug reactions (ADRs) remain one of the most persistent challenges. From infants to geriatric patients, vulnerable populations face increased risks due to physiology, absorption rates, drug interactions, and sometimes, even simple caregiver errors. In this post, we’ll not only unpack the science but also explore real-world stories, relevant statistics, and practical implications that make ADRs a constant concern for pharmacy professionals and students alike.

Why Infants and Children Are at Risk

The pediatric population presents unique challenges in pharmacology. Their physiology is still developing, which means that drug absorption, metabolism, and excretion differ greatly from adults.

Key Risk Factors

• Changing physiology: Infants and children metabolize drugs differently, leading to unpredictable outcomes.
• Poor absorption rates: Unlike adults, children may absorb drugs less effectively, delaying therapeutic effects.
• Toxicity risks: Proliferated absorption can paradoxically cause drug toxicity.

A Real-World Example

A 2017 review by Tolley et al. revealed that medication errors in pediatrics often stemmed from computerized order entry mistakes. In one case, a child was given nearly double the required dosage of a heart medication due to a misplaced decimal point, highlighting how fragile dosing accuracy is in pediatrics.

Caregivers are another point of vulnerability. Many parents and guardians lack adequate awareness of dosage requirements, which often leads to errors. In fact, the CDC estimates that more than 60,000 emergency visits each yearin the U.S. are due to accidental medication overdoses in children under 5.

Geriatric Patients and ADRs

If children are vulnerable due to underdeveloped physiology, the elderly face risks from the opposite direction: declining organ function and polypharmacy.

Why Geriatrics Are at Risk

• Drug interactions: Most elderly patients are on multiple medications, increasing the risk of dangerous interactions.
• Underlying diseases: Chronic conditions like hypertension, diabetes, or heart disease exacerbate ADR susceptibility.
• Delayed clearance: Reduced kidney and liver function mean that previously taken drugs may remain in the bloodstream, compounding new prescriptions.

Personal Story

Take the story of Mr. Kamau, an 82-year-old patient with hypertension and diabetes. Prescribed three different medications by two different specialists, he began experiencing dizziness and confusion. It turned out that one new prescription interacted negatively with his blood pressure medication, leading to hypotension episodes. This case illustrates how ADRs in geriatric care are not abstract risks but daily realities.

According to Woo & Robinson (2020), ADRs in older adults are often misdiagnosed as “normal aging,” which delays intervention and worsens outcomes.

📘 Tip: Need a research paper on geriatric pharmacology? Order from AceMyCourseWORK.com and get a thoroughly referenced paper that covers ADRs in the elderly with depth and precision.

Adrenergic Receptor Agonists: Benefits and Risks

Adrenergic receptor agonists are powerful tools in clinical practice. They stimulate alpha and beta receptors to achieve therapeutic goals but carry risks that demand caution.

Mechanism of Action

• Alpha-adrenergic receptors: Stimulate smooth muscles, leading to vasoconstriction.
• Beta-adrenergic receptors: Cause bronchodilation and lipolysis.

ADRs of Adrenergic Agonists

• Tachycardia
• Tremors
• Hypertension

Statistic Spotlight

Research from StatPearls (Farzam et al., 2023) notes that misuse or overdosing of adrenergic agonists accounts for nearly 15% of hospital admissions related to cardiovascular ADRs.

Adrenergic Antagonists: When the Balance Shifts

Adrenergic antagonists prevent adrenergic receptor stimulation and can suppress noradrenaline secretion. They are widely used in controlling heart conditions.

Clinical Use

• Management of arrhythmias
• Treatment of hypertension

ADRs

• Hypotension
• Nasal congestion

Case Insight

A study highlighted by Woo & Robinson (2020) showed that patients on beta-blockers reported higher incidences of fatigue and nasal congestion, ADRs that often cause noncompliance, complicating treatment outcomes.

Muscarinic Agonists and Their Adverse Effects

Muscarinic agonists mimic acetylcholine and play significant roles in smooth muscle contraction and glandular secretions.

Clinical Outcomes

• Smooth muscle contraction
• Increased glandular secretions

ADRs

• Bronchospasm
• Bradycardia

Story from Practice

In one hospital case, a patient treated with muscarinic agonists for glaucoma developed severe bronchospasms that required emergency intervention. This demonstrates how intended therapeutic benefits can tip dangerously into life-threatening ADRs if not closely monitored.

Anticholinergics: Blocking Acetylcholine

Anticholinergics selectively block muscarinic receptors, preventing acetylcholine from binding and causing stimulation.

Clinical Applications

• Respiratory disorder management
• Cardiac regulation
• Control of glandular secretions

ADRs

• Xerostomia (dry mouth)
• Tachycardia
• Urinary retention

Stat Insight

According to recent pharmacology reports, up to 30% of elderly patients on anticholinergics report urinary complications, making it one of the most common ADRs linked to this drug class.

FAQs on Adverse Drug Reactions in Pharmacy Practice

Q1: What are the most common ADRs in children?
A: Dosing errors leading to overdoses, allergic reactions, and gastrointestinal disturbances are common.

Q2: Why are elderly patients more prone to ADRs?
A: Reduced organ function, polypharmacy, and chronic illnesses increase their susceptibility.

Q3: Which drug classes have the highest ADR risks?
A: Adrenergic agonists/antagonists, muscarinic agonists, and anticholinergics are particularly high-risk due to their direct impact on vital organ systems.

Implications for Pharmacy Practice

The examples above show that adverse drug reactions in pharmacy practice are not isolated incidents but ongoing risks that affect all age groups. From pediatric dosing errors to geriatric drug interactions, pharmacy professionals must stay vigilant.

For students, writing about these topics requires more than memorization. It demands a critical analysis of how ADRs manifest in different populations and drug classes.

Conclusion: ADRs Are a Constant Challenge

The field of pharmacy practice continually grapples with preventing adverse drug reactions. Whether prescribing for infants, children, or the elderly, practitioners must consider physiology, drug interactions, and toxicity risks. Drug classes such as adrenergic agonists, antagonists, muscarinic agonists, and anticholinergics complicate the picture, offering therapeutic benefits while posing significant risks.

For pharmacy students and professionals alike, mastering the complexities of ADRs is not just academic — it is a matter of life and safety.

References

Farzam, K., Kidron, A., & Lakhkar, A. D. (2023). Adrenergic drugs. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK534230/
Tolley, C. L., Forde, N. E., Coffey, K. L., Sittig, D. F., Ash, J. S., Husband, A. K., Bates, D. W., & Slight, S. P. (2017). Factors contributing to medication errors made when using computerized order entry in pediatrics: A systematic review. Journal of the American Medical Informatics Association, 25(5), 575–584. https://doi.org/10.1093/jamia/ocx124
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (5th ed.). F. A. Davis Publishers.